吃完灵，可能是综合治疗正好那时候该好了，也说不定。 这药还在美国某些医院实验。 这里是美国医院招人参与实验的医院，还在招人 clinicaltrials.gov/ct2/results?cond=&term=paxlovid&cntry=US&state=&city=&dist= Doctor are clamoring for more clarity on Paxlovid prescribing amid Covid-19 rebound concern https://www.statnews.com/2022/07/07/paxlovid-prescribing-covid19-rebounds-data/ six months after regulators issued an emergency use authorization for Paxlovid, physicians say they still have significant questions about prescribing guidelines for the leading treatment for high-risk Covid patients. Scientists don’t yet have a clear understanding of why rebounds happen, or how prevalent they are. That has physicians uncertain about how much to take them into account when prescribing. “I think the sense of likely risk-benefit has changed over time,” said Walid Gellad, an internal medicine physician and health policy researcher at the University of Pittsburgh. “So I have a little more reluctance now than I did at the very beginning on prescribing.”
缺医少药情况下，我看到这些是比较好的方法减少重症和入院。Update: Techniques to aid recovery from a respiratory infection like COVID-19 - YouTube www.youtube.com/watch?v=X5QYsxdFLkI 这里是American College of Allergy, Asthma and Immunology教做这些会对肺好。养生堂上医生也有教Percussion - YouTube www.youtube.com/watch?v=1ZRk55sHJ1I NHS University Hospitals Plymouth Physiotherapy教的 How to breathe if you have a respiratory infection like COVID-19www.youtube.com/watch?v=sQwheE7wJZYAmerican College of Allergy, Asthma and Immunology教的另外还要保证吃喝！
吃完灵，可能是综合治疗正好那时候该好了，也说不定。 这药还在美国某些医院实验。 这里是美国医院招人参与实验的医院，还在招人 clinicaltrials.gov/ct2/results?cond=&term=paxlovid&cntry=US&state=&city=&dist= Doctor are clamoring for more clarity on Paxlovid prescribing amid Covid-19 rebound concern https://www.statnews.com/2022/07/07/paxlovid-prescribing-covid19-rebounds-data/ six months after regulators issued an emergency use authorization for Paxlovid, physicians say they still have significant questions about prescribing guidelines for the leading treatment for high-risk Covid patients. Scientists don’t yet have a clear understanding of why rebounds happen, or how prevalent they are. That has physicians uncertain about how much to take them into account when prescribing. “I think the sense of likely risk-benefit has changed over time,” said Walid Gellad, an internal medicine physician and health policy researcher at the University of Pittsburgh. “So I have a little more reluctance now than I did at the very beginning on prescribing.”
吃這藥的人 是有慢性病去諮詢醫生 醫生說 你可以吃 不吃也行 自己決定
lol，这个没想到